Development of cancer type-specific biomarker technology combing P450 fluorescence inhibition assay and machine learning<br/>

Ryotaro Oyama

[3P-869] Development of cancer type-specific biomarker technology combing P450 fluorescence inhibition assay and machine learning

^○Ryotaro Oyama¹, Hiromasa Imaishi² (1.Dept. of Life Sci., Grad Sch. of Agri., Univ. of Kobe, 2.Biosig. Res. Cen., Univ. of Kobe)

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

The 46th Annual Meeting of the Molecular Biology Society of Japan

[3P-869] Development of cancer type-specific biomarker technology combing P450 fluorescence inhibition assay and machine learning

Password